Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Temporary Equity And Stockholders' (Deficiency) Equity (Unaudited)

v3.7.0.1
Condensed Consolidated Statement of Changes in Temporary Equity And Stockholders' (Deficiency) Equity (Unaudited) - 6 months ended Jun. 30, 2017 - USD ($)
Series B Convertible Redeemable Preferred Stock [Member]
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Total
Balance beginning at Dec. 31, 2016 $ 429,153 $ (14,070) $ 80,102,189 $ (10,459,242) $ (67,631,569) $ 2,426,461
Balance beginning, shares at Dec. 31, 2016 42,915,379 4,411        
Series B preferred stock issued for cash $ 3,539,214
Series B preferred stock issued for cash, shares 353,921            
Common stock issued for cash, net of issuance costs of $4,500 $ 225 40,275 40,500
Common stock issued for cash, net of issuance costs of $4,500, shares 22,500          
Exchange of 8% notes for Series B preferred stock $ 1,267,324
Exchange of 8% notes for Series B preferred stock, shares 126,700            
Stock-based compensation: Common stock issued under 401(k) profit sharing plan $ 370 73,498 73,868
Stock-based compensation: Common stock issued under 401(k) profit sharing plan, shares 36,933          
Options and warrants 314,127 314,127
Net loss (3,739,583) (3,739,583)
Other comprehensive loss   3,768 3,768
Balance ending at Jun. 30, 2017 $ 4,806,538 $ 429,748 $ (14,070) $ 80,530,089 $ (10,455,474) $ (71,371,152) $ (880,859)
Balance ending, shares at Jun. 30, 2017 480,621 42,974,812 4,411